January 10, 2020

Constellation Pharmaceuticals

Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

January 09, 2020

Nurix

Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies

January 09, 2020

Jounce Therapeutics

Jounce Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 09, 2020

Editas Medicine

Editas Medicine Strengthens Executive Leadership Team To Support Long-Term Growth

January 09, 2020

Blueprint Medicines

Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Load More

Sign up for weekly portfolio news.